Retatrutide appears to be a new pharmaceutical in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By boosting these receptors, Retatrutide controls cravings, {promotesinsulin secretion, and ultimately contributes to significant slimming. While f